Who is Kikaku America International? Along with its unique network of legal, medical and business representatives, and consultants, Kikaku provides its clients with creative advertising and promotional services. With its American expertise and its understanding of the needs of Japanese pharmaceutical companies, Kikaku offers a unique service tailored to the needs of International and Japanese pharmaceutical companies, focusing on the specialized planning required by pharmaceutical, diagnostics, and device manufacturers to ensure the success of those preparing to enter the United States marketplace, and those who are currently doing business in the United States marketplace and globally.

Kikaku NETsendex improve your search engine optimization

Search engines can dramatically increase qualified traffic to your web site. Kikaku's NETsendex research pinpoints your search engine opportunity. Our NETsendex services with our Search Engine Optimization program, creates visibility on the top search engines. Just like industry leaders, your site will attract qualified visitors seeking health and treatment information. Click here to learn more

New Report on Dermatology and Plastic Surgery Practice Loyalty Just Released:

Building Practice Loyalty

The Renew Advantage Aesthetic Dermatology and Plastic Surgery Loyalty Trend Report examines challenges that dermatologists and plastic surgeons face in their practices, and offers solutions. The report combines survey research with expert commentary. Survey findings, based on responses of 137 plastic surgeons, dermatologists, and related professionals, reveal that most respondents want to increase their practices' cosmetic business but may lack a clear strategy. Other key findings include:

  • More than half of responding practices never survey their patients.
  • Only about a third of respondents incentivize staff to promote products/services.
  • Three-quarters of respondents don't know what it costs to land a new patient.
  • In one-quarter of practices, physicians order supplies.
  • Most respondents are unaware of the benefits of buying through a group purchasing organization.

Click here to download a free PDF copy of this report.

Click here to have the printed report mailed to you.

Two Reports on the Pharmacy Benefit Now Available:


Comprehensive Report Examines the Pharmacy Benefit From Three Key Perspectives

The 2010-2011 edition of The Boehringer Ingelheim Pharmacy Benefits Report reveals the experiences and expectations of employers, health plans, and pharmacy benefit managers/specialty pharmacy providers in designing and managing the pharmacy benefit. Research findings are analyzed and interpreted by industry experts. You can use the national data detailed in the report to benchmark your organization's policies and outcomes.

Among the report findings:

  • Medical costs are outpacing pharmacy costs
  • Diabetes and cancer are top cost concerns
  • Employers see clear link between employee health and productivity
  • Health plans are already using evidence-based research findings to alter formularies
  • Medication adherence is seen as key to improving health outcomes.

For your free copy of the complete report, click here.

Companion Report Focuses on Medicare Part D and the Medical Home

The 2010-2011 edition of The Boehringer Ingelheim Medicare Part D & Patient-Centered Medical Home Report examines the experiences and opinions of health plans in marketing to Medicare Part D beneficiaries and the extent to which health plans are embracing the medical home concept. Survey findings are analyzed by industry experts and supported by other research.

Among the report findings:

  • Part D plans are aggressively marketing to younger and healthier patient populations.
  • The top 5 therapeutic categories in drug spend are: diabetes, hyperlipidemia, hypertension, cancer, and depression.
  • Nearly one-third of Part D plan members reached the donut hole coverage gap in 2009.
  • Part D plans agree that widespread adoption of health information technology will improve patient outcomes.
  • Almost two-thirds of Part D plans support the medical home concept.

For your free copy of the complete report, click here.

Click to order
Click here to request your complimentary copy.


National Report Documents Attitudes, Practices, and Concerns of Long-Term Care Interdisciplinary Leaders

The Senior Care Digest Interdisciplinary Report: A Survey of Long-Term Care Health Professionals, is an annual report of long-term care leaders, including medical directors, consultant pharmacists, directors of nursing (DONs) and nurse practitioners (NPs). The report focuses on current issues such as prescribing and administration of controlled substances, disposal of unused drugs, use of social networking sites by practitioners, the value of gradual dose reductions, and involvement in facility-based research.

Click here to download a free PDF copy of this report.

The Multiple Sclerosis Trend Report

Teva Neuroscience and the National Multiple Sclerosis Society announce The Multiple Sclerosis Trend Report: Perspectives from Managed Care, Providers and Employers, Second Edition.

The National Multiple Sclerosis Society — in conjunction with a group of managed healthcare professionals, physicians,and academicians — researched current issues in the care of multiple sclerosis patients in order to assess trends in the management of MS.

The participants in this research were managed care organizations (MCOs); neurologists; specialty pharmacy companies; pharmacy benefit management companies, and employers.

The MS Trend Report
Maruho Co., Ltd has been awarded The American Academy of Dermatology 2010 Gold Triangle Award for the The Maruho Derma Report.

To read the latest Maruho Derma Report, Click here.
To browse all of the Maruho Derma Reports, Click here. Please note: Once you open the page with this link, you must click on the "O" button there in order to access the report list.


The Biologics Trend Report Sponsored By UCB, Volume 1

In this report, various industry stakeholders share their perspectives on the management and delivery of biologic treatments for Crohn's disease and rheumatoid arthritis. Managed care organizations, PBMs and specialty pharmacy providers, gastroenterologists, rheumatologists, and physicians’ reimbursement specialists participated in the research. They provided feedback on how they are managing these drugs in order to provide the best clinical outcomes while also achieving cost efficiencies and what some of the issues are that they must contend with throughout the process. The report is intended to help foster a collaborative approach in achieving practical, integrated solutions to the management of biologic therapies.

Click here to download a free PDF copy of this report.

Follow us on:

Bookmark and Share

replace with your keywords replace with your keywords replace with your keywords replace with your keywords replace with your keywords replace with your keywords replace with your keywords replace with your keywords